Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Giovanni Guaraldi, Marianna Meschiari, Alessandro Cozzi‐Lepri, Jovana Milić, Roberto Tonelli, Marianna Menozzi, Erica Franceschini, Gianluca Cuomo, Gabriella Orlando, Vanni Borghi, Antonella Santoro, Margherita Di Gaetano, Cinzia Puzzolante, Federica Carli, Andrea Bedini, Luca Corradi, Riccardo Fantini, Ivana Castaniere, Luca Tabbì, Massimo Girardis, Sara Tedeschi, Maddalena Giannella, Michele Bartoletti, Renato Pascale, Giovanni Dolci, Lucio Brugioni, Antonello Pietrangelo, Andrea Cossarizza, Federico Pea, Enrico Clini, Carlo Salvarani, Marco Massari, P. Viale, Cristina Mussini
Topics & Concepts
TocilizumabCoronavirus disease 2019 (COVID-19)MedicineRetrospective cohort studySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCohortVirologyInternal medicineOutbreakRheumatoid arthritisDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research